{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:30:21Z","timestamp":1786649421139,"version":"build-2736575974"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"\n Background:<\/jats:title>\n During continuous renal replacement therapy (CRRT), regional citrate anticoagulation (RCA) and bivalirudin are appealing alternatives since they provide excellent anticoagulation within the circuit without increasing the risk of bleeding. This study has been done to assess the hemofilter survival time, length of intensive care unit (ICU) stays, bleeding, thrombosis, and kidney function in bivalirudin and RCA.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n A total of 40 patients who needed CRRT were enrolled in the study with acute kidney injury (AKI). The patients were divided into two groups of 20 each. RCA was used in the CRRT in the first group and bivalirudin in the second group according to protocol. We have monitored serum urea, serum creatinine, last 24 h urine output, hemoglobin (Hb), platelet count, prothrombin time (PT), international normalized ratio (INR), serum albumin, any bleeding complication, or any transfusion requirement pre-CRRT, during CRRT, and after CRRT.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n \n Hemofilter life span was found significantly longer in the citrate group than the bivalirudin group (67.75 \u00b1 16.64 vs 50.65 \u00b1 7.98,\n P<\/jats:italic>\n < 0.001). Length of ICU stay is found to be non-significant between the groups (\n P<\/jats:italic>\n > 0.05). Significant difference was found in S. Creatinine level and urine output from pre-CRRT to post-CRRT in both the groups (\n P<\/jats:italic>\n < 0.05), but no significant difference was found in pre-CRRT, during CRRT, and post-CRRT between both the groups (\n P<\/jats:italic>\n > 0.05). No significant difference was found in terms of mortality, bleeding, and transfusion between the groups (\n P<\/jats:italic>\n > 0.05).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n After observing the data and statistical evaluation, we found that RCA has a better hemofilter life span than bivalirudin without a significant difference in mortality, bleeding, or transfusion.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/sja.sja_422_25","type":"journal-article","created":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T07:01:17Z","timestamp":1767337277000},"page":"74-81","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["A study of citrate and bivalirudin for anticoagulation during continuous renal replacement therapy in critically ill patients with acute kidney injury"],"prefix":"10.4103","volume":"20","author":[{"given":"Deepak","family":"Yadava","sequence":"first","affiliation":[{"name":"Department of Anesthesia and Critical Care, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Tripathi","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Critical Care, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujeet","family":"Rai","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Critical Care, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Malviya","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Critical Care, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suraj","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Critical Care, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namrata","family":"Rao","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smarika","family":"Mishra","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Critical Care, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,1,2]]},"reference":[{"issue":"5 Suppl 3","key":"R1-20260421","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S0272-6386(96)90073-6","article-title":"Nomenclature for continuous renal replacement therapies","volume":"28","author":"Bellomo","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"R2-20260421","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1159\/000060097","article-title":"Anticoagulation in continuous renal replacement therapy","volume":"132","author":"Schetz","year":"2001","journal-title":"Contrib Nephrol"},{"issue":"5 Suppl 4","key":"R3-20260421","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/S0272-6386(97)90538-2","article-title":"The coagulation system in the critically ill patient with acute renal failure and the effect of an extracorporeal circuit","volume":"30","author":"Davenport","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"R4-20260421","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/08860229809045097","article-title":"Hemostasis activation markers in acute renal failure","volume":"20","author":"Stefanidis","year":"1998","journal-title":"Ren Fail"},{"key":"R5-20260421","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1046\/j.1523-1755.1999.00397.x","article-title":"Activation of the tissue factor pathway occurs during continuous venovenous hemofiltration","volume":"55","author":"Cardigan","year":"1999","journal-title":"Kidney Int"},{"key":"R6-20260421","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1172\/JCI110945","article-title":"Cultured human endothelial cells generate tissue factor in response to endotoxin","volume":"71","author":"Colucci","year":"1983","journal-title":"J Clin Invest"},{"key":"R7-20260421","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/01.RES.72.5.1075","article-title":"Tissue factor is expressed on monocytes during simulated extracorporeal circulation","volume":"72","author":"Kappelmayer","year":"1993","journal-title":"Circ Res"},{"key":"R8-20260421","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000424631","article-title":"Antithrombin III deficiency during continuous venovenous hemodialysis","volume":"116","author":"Bastien","year":"1995","journal-title":"Contrib Nephrol"},{"key":"R9-20260421","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s001340050288","article-title":"Continuous venovenous haemofiltration using polyacrylonitrile filters does not activate contact system and intrinsic coagulation pathways","volume":"23","author":"Salmon","year":"1997","journal-title":"Intensive Care Med"},{"key":"R10-20260421","first-page":"169","article-title":"Short Filter Lifespan during Hemofiltration in sepsis: Antithrombin (AT) supplementation should be a good way to sort out this problem","volume":"23","author":"Joannes-Boyau","year":"2005","journal-title":"Blood Purificat"},{"key":"R11-20260421","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1001\/jama.288.12.1499","article-title":"Anemia and blood transfusion in critically ill patients","volume":"288","author":"Vincent","year":"2002","journal-title":"JAMA"},{"key":"R12-20260421","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1681\/ASN.V71145","article-title":"Heparin use in continuous renal replacement procedures: The struggle between filter coagulation and patient hemorrhage","volume":"7","author":"van de Wetering","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"R13-20260421","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1592\/phco.30.11.1117","article-title":"Bivalirudin versus unfractionated heparin for prevention of hemofilter occlusion during continuous renal replacement therapy","volume":"30","author":"Kiser","year":"2010","journal-title":"Pharmacotherapy"},{"key":"R14-20260421","first-page":"450","article-title":"Regional citrate anticoagulation for continuous renal replacement therapy","volume":"24","author":"Kindgen-Milles","year":"2018","journal-title":"Curr Opin Crit Care"},{"key":"R15-20260421","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1007\/s00134-015-4099-0","article-title":"Citrate versus heparin anticoagulation for continuous renal replacement therapy: An updated meta-analysis of RCTs","volume":"41","author":"Bai","year":"2015","journal-title":"Intensive Care Med"},{"key":"R16-20260421","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1177\/1751143717695835","article-title":"Evaluating the safety and efficacy of regional citrate compared to systemic heparin as anticoagulation for continuous renal replacement therapy in critically ill patients: A service evaluation following a change in practice","volume":"18","author":"Borg","year":"2017","journal-title":"J Intensive Care Soc"},{"key":"R17-20260421","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00134-011-2438-3","article-title":"Efficacy and safety of regional citrate anticoagulation in critically ill patients undergoing continuous renal replacement therapy","volume":"38","author":"Zhang","year":"2012","journal-title":"Intensive Care Med"},{"key":"R18-20260421","first-page":"1","article-title":"Acute kidney injury work group: KDIGO clinical practice guideline for acute kidney injury","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"R19-20260421","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000046075","article-title":"Citrate anticoagulation for extracorporeal circuits: Effects on whole blood coagulation activation and clot formation","volume":"89","author":"Calatzis","year":"2001","journal-title":"Nephron"},{"key":"R20-20260421","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1186\/s13054-015-1143-y","article-title":"Ionized calcium measurements during regional citrate anticoagulation in CRRT: We need better blood gas analyzers","volume":"19","author":"Kindgen-Milles","year":"2015","journal-title":"Crit Care"},{"key":"R21-20260421","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/00003246-200104000-00010","article-title":"Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation","volume":"29","author":"Meier-Kriesche","year":"2001","journal-title":"Crit Care Med"},{"key":"R22-20260421","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1159\/000524129","article-title":"A comparison of the commonly used surrogate markers for citrate accumulation and toxicity during continuous renal replacement therapy with regional citrate anticoagulation","volume":"51","author":"Anstey","year":"2022","journal-title":"Blood Purif"},{"key":"R23-20260421","first-page":"23","article-title":"Management of regional citrate anticoagulation for continuous renal replacement therapy: Guideline recommendations from Chinese emergency medical doctor consensus","volume":"10","author":"Liu","year":"2023","journal-title":"Mil Med Res"},{"key":"R24-20260421","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13054-015-0822-z","article-title":"Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: A randomized controlled trial","volume":"19","author":"Stucker","year":"2015","journal-title":"Crit Care"},{"key":"R25-20260421","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s13054-016-1299-0","article-title":"Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis with trial sequential analysis of randomized controlled trials","volume":"20","author":"Liu","year":"2016","journal-title":"Crit Care"},{"key":"R26-20260421","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s00134-003-2047-x","article-title":"Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: A prospective randomized study","volume":"30","author":"Monchi","year":"2004","journal-title":"Intensive Care Med"},{"key":"R27-20260421","doi-asserted-by":"crossref","first-page":"198","DOI":"10.4274\/cayd.galenos.2023.36693","article-title":"Comparison of Citrate and Heparin for Continuous Renal Replacement Therapy in Paediatric Intensive Units","volume":"10","author":"Botan","year":"2023","journal-title":"J Pediatr Emerg Intensive Care Med"},{"key":"R28-20260421","doi-asserted-by":"crossref","first-page":"1137134","DOI":"10.3389\/fmed.2023.1137134","article-title":"Heparin-based versus bivalirudin-based anticoagulation in pediatric extracorporeal membrane oxygenation: A systematic review","volume":"10","author":"Valdes","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"R29-20260421","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13054-019-2317-9","article-title":"Safety and efficacy of regional citrate anticoagulation for continuous renal replacement therapy in liver failure patients: A systematic review and meta-analysis","volume":"23","author":"Zhang","year":"2019","journal-title":"Crit Care"},{"key":"R30-20260421","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1177\/03913988241269492","article-title":"Regional citrate anticoagulation versus LMWH anticoagulation for CRRT in liver failure patients without increased bleeding risk","volume":"47","author":"Tang","year":"2024","journal-title":"Int J Artif Organs"},{"key":"R31-20260421","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1038\/s41598-022-05867-8","article-title":"Citrate pharmacokinetics in critically ill liver failure patients receiving CRRT","volume":"12","author":"Thanapongsatorn","year":"2022","journal-title":"Sci Rep"}],"container-title":["Saudi Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/sja.sja_422_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:53:59Z","timestamp":1786647239000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/sja.sja_422_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/sja.sja_422_25","relation":{},"ISSN":["1658-354X","0975-3125"],"issn-type":[{"value":"1658-354X","type":"print"},{"value":"0975-3125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2025-05-25","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}